B3Impact of metabolic syndrome on clinical outcome of castration resistant prostate cancer (CRPC) patients treated with abiraterone and enzalutamideVincenza Conteduca,O. Caffo,Luca Galli,Antonio Maugeri,Emanuela Scarpi,Francesca Maines,Vincenzo Emanuele Chiuri,Cristian Lolli,Stefania Kinspergher,Giuseppe Schepisi,Matteo Santoni,Daniele Santini,L. Fratino,S.L. Burgio,Samanta Salvi,Cecilia Menna,U. De GiorgiAnnals of Oncology（2017）引用 1|浏览22暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
